Objective: Chronic obstructive pulmonary disease (COPD) is associated with various immunopathophysiological pathways. Therefore, several inflammatory, hematological and immunological biomarkers are essential for diagnosis, prognosis, and survival of COPD. Among these inflammatory markers, such as C-reactive protein (CRP), neutrophil, lymphocyte and platelet counts were shown to have strong correlations with prognosis, survival and mortality. Recently, a novel inflammatory marker stated as systemic immune-inflammation index (SII) were presented as the most accurate in predicting inflammatory status and prognosis in various clinical settings. We aimed to investigate whether SII can be a useful tool for predicting prognosis and survival in COPD patients.
Alan : Sağlık Bilimleri
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|